Jaishri O. Blakeley

Also affiliated with Johns Hopkins Medicine

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 31 papers. Top paper: “Selumetinib in Children with Inoperable Plexiform Neurofibromas”.

Selumetinib in Children with Inoperable Plexiform Neurofibromas

New England Journal of Medicine(2020)10.1056/nejmoa1912735

N/A

9.0DataRank · unranked

708 citations

Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Patricia Whitcomb, Michael J. Fisher +24 more

Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas

Neuro-Oncology(2023)10.1093/neuonc/noad086

N/A

2.3DataRank · unranked

97 citations

Eva Dombi, Pamela L. Wolters, Andrea Baldwin, Anne Dufek, Kailey R. Herrera +14 more

Cabozantinib for neurofibromatosis type 1–related plexiform neurofibromas: a phase 2 trial

Nature Medicine(2021)10.1038/s41591-020-01193-6

N/A

2.0DataRank · unranked

96 citations

Chie‐Schin Shih, Steven D. Rhodes, Amy E. Armstrong, Pamela L. Wolters, Eva Dombi +25 more

Selumetinib in children with neurofibromatosis type 1 and asymptomatic inoperable plexiform neurofibroma at risk for developing tumor-related morbidity

Neuro-Oncology(2022)10.1093/neuonc/noac109

N/A

1.7DataRank · unranked

66 citations

Brittany Glassberg, Pamela L. Wolters, Eva Dombi, Andrea Baldwin, Michael J. Fisher +18 more

Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1

Genes(2020)10.3390/genes11020226

N/A

0.751DataRank · unranked

21 citations

Robert J. Allaway, Jaclyn N. Taroni, Aaron Baker, Xiaochun Zhang, Chang In Moon +7 more

Integrative analysis identifies candidate tumor microenvironment and intracellular signaling pathways that define tumor heterogeneity in NF1

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.01.13.904771

N/A

0.208DataRank · unranked

3 citations

Robert J. Allaway, Jaclyn N. Taroni, Aaron Baker, Xiaochun Zhang, Chang In Moon +7 more

Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma

medRxiv(2021)10.1101/2021.09.09.21262860

N/A

0DataRank · unranked

1 citations

Christopher Douville, Natalie Silliman, Janine Ptak, Lisa Dobbyn, Joy Schaefer +10 more

Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation

Genetics in Medicine(2022)10.1016/j.gim.2022.05.007

N/A

0DataRank · unranked

278 citations

Ludwine Messiaen, Eric Legius, Patrice Pancza, Robert A. Avery, Jaishri O. Blakeley +79 more

Review and consensus recommendations on clinical APT‐weighted imaging approaches at 3T: Application to brain tumors

Magnetic Resonance in Medicine(2022)10.1002/mrm.29241

N/A

0DataRank · unranked

231 citations

Moritz Zaiß, Linda Knutsson, Phillip Zhe Sun, Sung Soo Ahn, Silvio Aime +31 more

Radiomics analysis of amide proton transfer‐weighted and structural MR images for treatment response assessment in malignant gliomas

NMR in Biomedicine(2022)10.1002/nbm.4824

N/A

0DataRank · unranked

15 citations

Pengfei Guo, Hye‐Young Heo, Yi Zhang, Jingpu Wu, Y Jin +5 more

Learning-based analysis of amide proton transfer-weighted MRI to identify true progression in glioma patients

NeuroImage Clinical(2022)10.1016/j.nicl.2022.103121

N/A

0DataRank · unranked

13 citations

Mathias Unberath, Hye‐Young Heo, Charles G. Eberhart, Michael Lim, Jaishri O. Blakeley +2 more

Therapeutic Vulnerability to ATR Inhibition in Concurrent NF1 and ATRX-Deficient/ALT-Positive High-Grade Solid Tumors

Cancers(2022)10.3390/cancers14123015

N/A

0DataRank · unranked

17 citations

Charles G. Eberhart, Christine A. Pratilas, Jaishri O. Blakeley, Christine Davis, Marija Stojanova +5 more

Proceedings of the Survivorship Care in Neuro-Oncology Workshop sponsored by the Comprehensive Oncology Network Evaluating Rare CNS Tumors (NCI-CONNECT)

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac029

N/A

0DataRank · unranked

6 citations

Emily S. Tonorezos, Deborah K. Mayer, Marie Bakitas, Susan M. Chang, Mary E. Cooley +75 more

Therapeutic vulnerability to ATR inhibition in concurrent NF1 and ATRX- deficient high-grade solid tumors

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.03.479021

N/A

0DataRank · unranked

3 citations

Charles G. Eberhart, Christine A. Pratilas, Jaishri O. Blakeley, Christine Davis, Marija Stojanova +5 more

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis

medRxiv(2022)10.1101/2022.03.31.22273208

N/A

0DataRank · unranked

0 citations

Jan M. Friedman, Laura J. Klesse, Kaleb Yohay, Justin T. Jordan, Scott R. Plotkin +3 more

Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1

Neuro-Oncology(2023)10.1093/neuonc/noad033

N/A

0DataRank · unranked

35 citations

Anna F. Piotrowski, Jian Campian, Jose Diarte, Fausto J. Rodríguez, Tejus Bale +7 more

Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0585

N/A

0DataRank · unranked

27 citations

Sushant Puri, Yingying Sang, Meihui Jessica Shi, Lindsay Blair, Jaishri O. Blakeley +2 more

Cutaneous Neurofibroma Heterogeneity: Factors that Influence Tumor Burden in Neurofibromatosis Type 1

Journal of Investigative Dermatology(2023)10.1016/j.jid.2022.12.027

N/A

0DataRank · unranked

20 citations

Renée M. McKay, Sang Yong Lee, Carlos G. Romo, Jaishri O. Blakeley, Muzlifah Haniffa +5 more

Druggable genomic landscapes of high-grade gliomas

Frontiers in Medicine(2023)10.3389/fmed.2023.1254955

N/A

0DataRank · unranked

14 citations

Maria Fatteh, David Kamson, Archana Balan, Michael Chang, Jessica J. Tao +8 more

Consensus-Based Best Practice Guidelines for the Management of Spinal Deformity and Associated Tumors in Pediatric Neurofibromatosis Type 1: Screening and Surveillance, Surgical Intervention, and Medical Therapy

Journal of Pediatric Orthopaedics(2023)10.1097/bpo.0000000000002431

N/A

0DataRank · unranked

9 citations

Krishna V. Suresh, Jaime A. Gómez, John B. Emans, A. Noelle Larson, Patrick J. Cahill +18 more

CEST2022: Amide proton transfer-weighted MRI improves the diagnostic performance of multiparametric non-contrast-enhanced MRI techniques in patients with post-treatment high-grade gliomas

Magnetic Resonance Imaging(2023)10.1016/j.mri.2023.06.003

N/A

0DataRank · unranked

10 citations

Jingpu Wu, Nhat Le, Yiqing Shen, Pengfei Guo, Karisa C. Schreck +16 more

Perspectives of adolescents with neurofibromatosis 1 and cutaneous neurofibromas: Implications for clinical trials

Clinical Trials(2023)10.1177/17407745231178839

N/A

0DataRank · unranked

6 citations

Kavita Y. Sarin, Andrea Petersen, Dominique C. Pichard, Pamela L. Wolters, Gregg Erickson +8 more

Recommendations for the collection and annotation of biosamples for analysis of biomarkers in neurofibromatosis and schwannomatosis clinical trials

Clinical Trials(2023)10.1177/17407745231203330

N/A

0DataRank · unranked

3 citations

Steven D. Rhodes, Edina Komlódi-Pásztor, Herb Sarnoff, Vito Grasso, Meena Upadhyaya +6 more

Expanding therapeutic options for people with NF2-related schwannomatosis: Encouraging results with brigatinib

Neuro-Oncology(2024)10.1093/neuonc/noae137

N/A

0DataRank · unranked

3 citations

Jaishri O. Blakeley, Scott R. Plotkin

Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors

Nature Communications(2025)10.1038/s41467-025-63619-4

N/A

0DataRank · unranked

2 citations

Jingyi Shi, Jianan Liu, Nihao Sun, Yuqing Lu, Xiaojun Chen +13 more

Establishing the content validity of patient-reported outcome measures used in neuro-oncology based on the WHO ICF framework: Part of the RANO-PRO initiative

Neuro-Oncology(2025)10.1093/neuonc/noaf108

N/A

0DataRank · unranked

0 citations

Linda Dirven, Tobias Walbert, Terri S. Armstrong, David Arons, Martin J. van den Bent +24 more

Mebendazole and temozolomide in patients with newly diagnosed high-grade gliomas: results of a phase 1 clinical trial

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa154

N/A

0DataRank · unranked

44 citations

Matthias Holdhoff, Henry Brem, Avadhut D. Joshi, Christine L. Hann, Ren-Yuan Bai +12 more

Early administration of imatinib mesylate reduces plexiform neurofibroma tumor burden with durable results after drug discontinuation in a mouse model of neurofibromatosis type 1

Pediatric Blood & Cancer(2020)10.1002/pbc.28372

N/A

0DataRank · unranked

5 citations

Steven D. Rhodes, Abbi E. Smith, Shi Chen, Waylan Bessler, Michael J. Ferguson +10 more

Therapy for Diffuse Astrocytic and Oligodendroglial Tumors in Adults: ASCO-SNO Guideline

Journal of Clinical Oncology(2021)10.1200/jco.21.02036

N/A

0DataRank · unranked

191 citations

Hans Messersmith, Na Tosha Gatson, Andreas F. Hottinger, Andrew B. Lassman, Jordan Morton +14 more

Early phase clinical studies of AR‐42, a histone deacetylase inhibitor, for neurofibromatosis type 2‐associated vestibular schwannomas and meningiomas

Laryngoscope Investigative Otolaryngology(2021)10.1002/lio2.643

N/A

0DataRank · unranked

37 citations

Katharine A. Collier, Sarah S. Burns, Janet L. Oblinger, Edina Shu, Beth A. Miles‐Markley +10 more

Phase 0 Clinical Trial of Everolimus in Patients with Vestibular Schwannoma or Meningioma

Molecular Cancer Therapeutics(2021)10.1158/1535-7163.mct-21-0143

N/A

0DataRank · unranked

23 citations

Audrey Mauguen, Ekrem Maloku, Qingwen Xu, Erin Dunbar, Scott R. Plotkin +17 more